At the IGTP TODAY

News

Manremyc opens a funding round of 250,000 euros through the Capital Cell platform

Manremyc, a spin-off of the IGTP specialised in the development of a probiotic against tuberculosis, has opened a funding round through Capital Cell, the first on-line investment platform in Europe specialized in biomedicine. The objective of the campaign is to reach 250,000 euros, with a minimum investment requirement per person of only 600 euros. Up to now, the company has secured 35% of the investment, which includes participation from the Reig family, main shareholders in the pharmaceutical company Reig Jofre.

Mireia Belmonte presents her new watch in support of Campus Can Ruti

Mireia Belmonte the Olympic swimming medallist from Badalona visited the Germans Trias i Pujol Research Institute (IGTP) on Campus Can Ruti on Wednesday 29 May. The event marked the start of a collaboration in support of the Amics de Can Ruti (Friends of Can Ruti) to raise awareness of the importance of health research. During her visit, she presented a watch, which she helped to design, that will soon be available through the web and events organized by the Amics de Can Ruti. All proceeds from the sales of the watch will go to research projects on the campus.

- Research

The IGTP participates in the debates of the 11th Research Workshop of the ICS: childhood obesity and rare diseases

Experts in paediatric research agree on the need to anticipate and act on obesity from childhood. The importance of early interventions to prevent obesity and excess weight and research into rare diseases have been the main topics of the 11th Research Workshop of the Catalan Institute of Health (ICS), which took place at the Seminari de Tarragona (Centre Tarraconense).

- Campus Can Ruti, Research

Surgeons in the Germans Trias Hospital are awarded a Llavor grant to commercialize a new surgical device

The project Mechanical atraumatic microvascular sutures has been awarded a Llavor grant (Seed Grant) by the Catalan Agency for Management of University and Research Grants (AGAUR). This research project is led by Dr M Carmen Higueras Suñé, Head of the Plastic Surgery Service at the Germans Trias Hospital, and the scientist responsible for the commercial development of the device is Dr David Priego, a specialist surgeon in the same department in the hospital.

- Innovation, Research

Aniling is among the projects selected for this year’s CRAASH Barcelona Programme

Ten international projects have been selected for the second edition of CRAASH Barcelona and Aniling is one of them.  CRAASH is the business acceleration programme organized by Biocat and CIMIT (Boston). Aniling is a spin-off company of the IGTP, which has developed a method for analysing the genome and epigenome of a patient simultaneously, an advance in personalized medicine for both research and clinical settings.